TSX:CURAPharmaceuticals
Is Curaleaf Still Attractive After a 92% Year To Date Surge?
Wondering if Curaleaf Holdings is still a smart way to play the US cannabis recovery, or if the easy upside has already been priced in? You are not alone.
The stock has been on a wild ride, down 13.5% over the last week but still up 63.9% in the past month, 91.7% year to date, and 108.0% over the last year, even though 3 and 5 year returns remain deeply negative.
Recent moves have been fueled by optimism around US cannabis reform and Curaleaf’s ongoing expansion in key states. This has...